Plasma leptin levels correlated with 28‐joint disease activity score and IL‐17 in RA patients with conventional pharmacological treatment, which suggested that leptin could be a biomarker of long‐term disease 31. The gene discussed is IL17A; the disease is rheumatoid arthritis.